Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial peptidoglycan (PGN), also known as murein, is an essential and unique structural polymer that forms a mesh-like layer outside the cytoplasmic membrane of most bacteria (StatPearls, 2023). It consists of long glycan strands composed of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) residues, which are cross-linked by short peptide chains to provide mechanical strength and maintain cell shape (Nature Reviews Microbiology, 2019). This structure is critical for protecting the bacterium from osmotic lysis due to high internal pressure. Because peptidoglycan is absent in eukaryotic cells, it serves as a highly specific and effective target for antibacterial agents. Glycopeptide antibiotics, such as vancomycin, exert their effect by binding directly to the D-alanyl-D-alanine terminus of the peptidoglycan precursors, thereby inhibiting the assembly and cross-linking of the glycan strands (PubChem, 2024). Additionally, the enzyme lysozyme, a key component of the innate immune system, targets this molecule by hydrolyzing the beta-1,4-glycosidic bonds between NAM and NAG, leading to cell wall degradation and bacterial death (Microbiology and Molecular Biology Reviews, 2006).
Inhibition of cell wall synthesis by binding to the D-alanyl-D-alanine terminus of peptidoglycan precursors, preventing polymerization and cross-linking of glycan strands (PubChem, 2024). Enzymatic hydrolysis of the beta-1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine residues in the glycan backbone (Microbiology and Molecular Biology Reviews, 2006).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial peptidoglycan (PGN) (PGN).